H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-05-15,CFO,BLOCH KATHLEEN P. ,卖出,12400普通股, $8.75
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-05-15,CFO,BLOCH KATHLEEN P. ,期权,12400普通股, $4.69
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-05-16,CFO,BLOCH KATHLEEN P. ,卖出,12400普通股, $9.00
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-05-16,CFO,BLOCH KATHLEEN P. ,期权,12400普通股, $4.69
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-05-14,CFO,BLOCH KATHLEEN P. ,卖出,10000普通股, $8.50
$Cytosorbents Corporation(CTSO)$ 内部交易: 2018-05-14,CFO,BLOCH KATHLEEN P. ,期权,10000普通股, $2.90
$Cytosorbents Corporation(CTSO)$ 8-K - Current report Filed: 2018-05-09 AccNo: 0001144204-18-026219 Size: 118 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents Corporation(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-08 AccNo: 0001144204-18-026127 Size: 4 MB 网页链接
$Cytosorbents Corporation(CTSO)$ 美东时间 2018-05-08 盘后 披露财报,预期EPS -0.13 网页链接
$Cytosorbents Corporation(CTSO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-04-25 AccNo: 0001144204-18-022194 Size: 800 KB 网页链接